Back to Journals » Therapeutics and Clinical Risk Management » Volume 17 » More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features
Please verify you are not a robot.